iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE – Get Free Report)’s share price traded up 0.8% during trading on Wednesday . The stock traded as high as $31.43 and last traded at $31.30. 12,858 shares changed hands during trading, an increase of 138% from the average session volume of 5,402 shares. The stock had previously closed at $31.06.
iShares LifePath Target Date 2045 ETF Stock Performance
The firm’s 50-day simple moving average is $31.57 and its 200 day simple moving average is $31.62. The company has a market cap of $24.41 million, a P/E ratio of 21.45 and a beta of 0.90.
Institutional Trading of iShares LifePath Target Date 2045 ETF
An institutional investor recently bought a new position in iShares LifePath Target Date 2045 ETF stock. Heck Capital Advisors LLC bought a new stake in shares of iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 869 shares of the company’s stock, valued at approximately $27,000. Heck Capital Advisors LLC owned about 0.27% of iShares LifePath Target Date 2045 ETF as of its most recent filing with the SEC.
About iShares LifePath Target Date 2045 ETF
The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.
Further Reading
- Five stocks we like better than iShares LifePath Target Date 2045 ETF
- What Do S&P 500 Stocks Tell Investors About the Market?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Overbought Stocks Explained: Should You Trade Them?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What does consumer price index measure?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for iShares LifePath Target Date 2045 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2045 ETF and related companies with MarketBeat.com's FREE daily email newsletter.